Daily Intelligence Brief
Depo-Provera and Talc Dockets Lead Quantitative Surge as Gori Law Aggressively Populates MDL 3140
Depo-Provera Products Liability Litigation (MDL 3140) and Johnson & Johnson Talcum Powder Litigation (MDL 2738) accounted for the highest volume of new actions yesterday, with federal dockets registering 67 new mass tort filings across all monitored litigations. The Depo-Provera Products Liability Litigation absorbed 12 new complaints alleging a link between the contraceptive injection and intracranial tumors, with Gori Law Firm PC driving the momentum through a concentrated block of six filings, heavily supported by Morris Bart. Simultaneously, the Johnson & Johnson Talcum Powder Litigation saw an influx of 10 new cases, anchored by Napoli Shkolnik and Wagstaff Law Firm. This volume leadership stands in contrast to the GLP-1 Receptor Agonists Litigation (MDL 3094) docket, which recorded six new filings, five of which were spearheaded by Morgan & Morgan PA.Corporate Liability for Sexual Exploitation Intensifies Amidst Bellwether Trial Preparations
Litigation targeting corporate failures to prevent sexual assault and exploitation continues to expand across multiple industries, with a sharp focus on institutional liability. Singleton Schreiber LLP and the team of Bondurant Mixson & Elmore initiated high-priority claims in the G6 Hospitality Sex Trafficking Litigation and Wyndham Hotels and Resorts Sex Trafficking Litigation, targeting alleged franchisor failures to prevent exploitation. While the JPML previously denied MDL consolidation for hotel TVPRA claims, these new filings signal an aggressive decentralized strategy by plaintiffs. In the ride-share sector, the Uber Technologies, Inc., Passenger Sexual Assault Litigation (MDL 3084) is bracing for its second bellwether trial (Case WHB 823), set to begin jury selection this coming Monday, April 13. This follows a landmark $8.5 million verdict in the first bellwether, which established a strong liability framework for failure to implement adequate safety measures. Simultaneously, the Roblox Child Sexual Exploitation/Assault Litigation (MDL 3166) saw new actions from Corrie Yackulic Law Firm and C.A. Goldberg, as the recently appointed Plaintiffs' Executive Committee begins coordinating discovery.9/11 Legacy Litigation Evolves with Critical Amendments as Medical Device Bellwethers Loom
Beyond current volume leaders, significant procedural maneuvering has occurred in both legacy and emerging dockets that signal critical pivots for practitioners. In the Terrorist Attacks on September 11, 2001 Litigation (MDL 1570), Sullivan Papain Block McManus Coffinas & Cannavo PC submitted two critical amended complaints in the Southern District of New York, refining claims under the Justice Against Sponsors of Terrorism Act (JASTA) against foreign sovereigns and aviation defendants. In medical device litigation, the Bard PowerPort Products Liability Litigation is preparing for its first bellwether trial in Robert Cook v. C.R. Bard on April 21, 2026, in the District of Arizona, while the Dupixent (Dupilumab) Products Liability Litigation (MDL 3180) centralization bid has gained decisive momentum following reports that manufacturers Sanofi and Regeneron have agreed to consolidation. Furthermore, the regulatory landscape for the Ethylene Oxide (EtO) Litigation remains volatile; following an April 1 EPA public hearing, the agency is facing a May 1 deadline for comments on proposed rollbacks to the 2024 emission standards, a move that would significantly increase the weight of state-court 'failure-to-warn' trials for impacted communities.Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.
